Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells

One of the major targets for breast cancer therapy is the epidermal growth factor receptor (EGFR) and related receptors, which signal via different signal transduction pathways including the mitogen-activated protein kinase (MAPK) pathway. This study determined whether there is a correlation between...

Descripción completa

Detalles Bibliográficos
Autores principales: Lev, D C, Kim, L S, Melnikova, V, Ruiz, M, Ananthaswamy, H N, Price, J E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364773/
https://www.ncbi.nlm.nih.gov/pubmed/15280923
http://dx.doi.org/10.1038/sj.bjc.6602051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364773/
https://www.ncbi.nlm.nih.gov/pubmed/15280923
http://dx.doi.org/10.1038/sj.bjc.6602051

Ejemplares similares